Article

Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: Evidence supporting targeted screening

Center for the Evaluation of Risks to Human Reproduction, National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709-2233, USA.
COPD Journal of Chronic Obstructive Pulmonary Disease (Impact Factor: 2.62). 09/2006; 3(3):133-9. DOI: 10.1080/15412550600829257
Source: PubMed

ABSTRACT Alpha-1 antitrypsin deficiency is known as a significant genetic risk factor for COPD for carriers of phenotype PIMZ, and for phenotypes PIZZ and PISZ. Genetic epidemiological studies for alpha-1 antitrypsin deficiency conducted by others on both COPD patients and concurrent non-COPD controls were used to estimate the risk factors for all six phenotypic classes (namely, the normal phenotype PIMM, and the 5 deficiency allele phenotypes: PIMS, PIMZ, PISS, PISZ, and PIZZ). Studies on alpha-1 antitrypsin deficiency in white (Caucasian) COPD and non-COPD populations in 6 countries were combined to obtain estimates of the prevalence of the PIS and PIZ deficiency alleles in the combined COPD and non-COPD cohorts. The odds ratios for each of the six phenotypic classes of alpha-1 antitrypsin deficiency were calculated for a hypothetical population of 19.3 million white COPD patients in the United States of America. This approach demonstrated that 1,829,673 alpha-1 antitrypsin deficiency patients would be detected by testing 19.3 million white COPD patients and 536,033 in white non-COPD concurrent controls. The odds ratios for each of the phenotypic classes among white COPD patients demonstrate highly significant decreases in the normal phenotype PIMM, no significant change in the PIMS and PISS deficiency phenotypes, but highly significant increases in the prevalences of the PIMZ, PISZ, and PIZZ deficiency phenotypes. The result of the present study supports the concept of targeted screening for alpha-1 antitrypsin deficiency in countries with large populations of white (Caucasian) COPD patients.

2 Followers
 · 
248 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper presents the results of studies on the arc-proofness of insulating booms of aerial platforms for live line works. The data obtained with 5-20 kA power arcs applied for 1.5-0.1 sec, show acceptable arc-proofness of tested insulating boom samples and full-scale models as well as their ability to withstand nominal voltage or even switching overvoltages after such an arc, if autoreclosing occurs during live line work. The obtained results make possible further improvements of existing telescopic platforms
    Transmission and Distribution Construction and Live Line Maintenance, 1993. Proceedings from ESMO-93., Sixth International Conference on; 10/1993
  • [Show abstract] [Hide abstract]
    ABSTRACT: Alpha1-antitrypsin deficiency is a genetic disorder which contributes to the development of chronic obstructive pulmonary disease, bronchiectasis, liver cirrhosis and panniculitis. The discovery of alpha1-antitrypsin and its function as an antiprotease led to the protease-antiprotease hypothesis, which goes some way to explaining the pathogenesis of emphysema. This article will review the clinical features of alpha1-antitrypsin deficiency, the genetic mutations known to cause it, and how they do so at a molecular level. Specific treatments for the disorder based on this knowledge will be reviewed, including alpha1-antitrypsin replacement, gene therapy and possible future therapies, such as those based on stem cells.
    Respiration 02/2007; 74(5):481-92. DOI:10.1159/000105536 · 2.92 Impact Factor
  • Revue des Maladies Respiratoires 10/2007; 24:7-17. DOI:10.1016/S0761-8425(07)92773-4 · 0.49 Impact Factor
Show more

Full-text

Download
83 Downloads
Available from
May 26, 2014